Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Growth of Cartilage and Bone Tissue01:27

Growth of Cartilage and Bone Tissue

4.9K
Chondrocytes form a temporary cartilaginous model by dividing and secreting a thick gel-like extracellular matrix. Once the chondrocytes undergo programmed cell death, osteoblasts enter the site of the cartilaginous model. The process of replacing the temporary cartilaginous model with bone in an ordered manner is called endochondral ossification. In endochondral ossification, not all of the cartilage is replaced by bone tissue. Some cartilage that performs a protective and supportive function...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Finding our ROLE: How and why to reframe essentialist approaches to language.

Cognition·2026
Same author

Advances in antimicrobial orthopaedic devices and FDA regulatory challenges.

Progress in biomedical engineering (Bristol, England)·2024
Same author

Social Expectation Improves Speech Perception in Noise.

Language and speech·2016
Same author

The socially weighted encoding of spoken words: a dual-route approach to speech perception.

Frontiers in psychology·2014
Same author

Mitigating adverse event reporting bias in spine surgery.

The Journal of bone and joint surgery. American volume·2013
Same author

The time course of perception of coarticulation.

The Journal of the Acoustical Society of America·2013

Related Experiment Video

Updated: Apr 10, 2026

Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model
08:58

Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model

Published on: May 21, 2013

14.8K

Regulatory Challenges for Cartilage Repair Technologies.

Kevin B McGowan1, Glenn Stiegman1

  • 1Musculoskeletal Clinical Regulatory Advisers, Washington, DC, USA.

Cartilage
|June 13, 2015
PubMed
Summary

Navigating the Food and Drug Administration (FDA) approval process for cartilage repair products is complex. Strategic planning of clinical trials and regulatory pathways is crucial for timely market access.

Keywords:
FDAarticular cartilageclinical trialsregulatory affairs

More Related Videos

Development and Evaluation of a Rat Model of Full-Thickness Cartilage Defects
04:34

Development and Evaluation of a Rat Model of Full-Thickness Cartilage Defects

Published on: May 19, 2023

2.6K
3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation
12:37

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation

Published on: October 7, 2015

20.8K

Related Experiment Videos

Last Updated: Apr 10, 2026

Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model
08:58

Matrix-assisted Autologous Chondrocyte Transplantation for Remodeling and Repair of Chondral Defects in a Rabbit Model

Published on: May 21, 2013

14.8K
Development and Evaluation of a Rat Model of Full-Thickness Cartilage Defects
04:34

Development and Evaluation of a Rat Model of Full-Thickness Cartilage Defects

Published on: May 19, 2023

2.6K
3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation
12:37

3D Hydrogel Scaffolds for Articular Chondrocyte Culture and Cartilage Generation

Published on: October 7, 2015

20.8K

Area of Science:

  • Orthopedics
  • Biomaterials Science
  • Regulatory Science

Background:

  • Limited Food and Drug Administration (FDA)-approved treatments are available for focal cartilage and osteochondral lesions in the U.S.
  • Product developers encounter significant hurdles in obtaining FDA marketing approval for cartilage repair innovations.

Purpose of the Study:

  • To delineate the essential steps for FDA application and approval of novel cartilage repair products.
  • To provide insights into the regulatory landscape for cartilage repair therapies.

Main Methods:

  • Review of FDA Guidance Documents, FDA Panel Meetings, scientific organization recommendations, and clinicaltrials.gov.
  • Analysis of current FDA and scientific community perspectives on the regulatory process for cartilage repair.

Main Results:

  • Cartilage repair products may be approved as medical devices, drugs, or biologics, influencing regulatory strategies.
  • FDA guidance offers general requirements, necessitating careful design of study populations, comparators, and endpoints.
  • Early consideration of regulatory strategy and manufacturing validation is vital for efficient product approval.

Conclusions:

  • The regulatory pathway for cartilage repair therapies is challenging and lengthy.
  • Meticulous clinical trial planning and attention to detail can expedite product market entry, saving time and resources.